These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis. Dos Santos IB, da Silva DAM, Paz FACR, Garcia DM, Carmona AK, Teixeira D, Longo-Maugéri IM, Katz S, Barbiéri CL. Front Microbiol; 2018; 9():1427. PubMed ID: 30018604 [Abstract] [Full Text] [Related]
4. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate. Ferreira BA, Coser EM, de la Roca S, Aoki JI, Branco N, Soares GHC, Lima MIS, Coelho AC. PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213 [Abstract] [Full Text] [Related]
8. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B. Velásquez AMA, Ribeiro WC, Venn V, Castelli S, Camargo MS, de Assis RP, de Souza RA, Ribeiro AR, Passalacqua TG, da Rosa JA, Baviera AM, Mauro AE, Desideri A, Almeida-Amaral EE, Graminha MAS. Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113 [Abstract] [Full Text] [Related]
9. Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule. da Silva DAM, Santana FR, Katz S, Garcia DM, Teixeira D, Longo-Maugéri IM, Barbiéri CL. Front Immunol; 2020 Aug; 11():345. PubMed ID: 32194563 [Abstract] [Full Text] [Related]
10. Nanoparticles Loaded with a New Thiourea Derivative: Development and In vitro Evaluation Against Leishmania amazonensis. Meireles PW, de Souza DPB, Rezende MG, Borsodi MPG, de Oliveira DE, da Silva LCRP, de Souza AMT, Viana GM, Rodrigues CR, do Carmo FA, de Sousa VP, Rossi-Bergmann B, Cabral LM. Curr Drug Deliv; 2020 Aug; 17(8):694-702. PubMed ID: 32621717 [Abstract] [Full Text] [Related]
13. In Vitro and In Vivo Antileishmanial Activity of Thioridazine. Sifontes-Rodríguez S, Mollineda-Diogo N, Monzote-Fidalgo L, Escalona-Montaño AR, Escario García-Trevijano JA, Aguirre-García MM, Meneses-Marcel A. Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122 [Abstract] [Full Text] [Related]
15. Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses. Paladi CS, da Silva DA, Motta PD, Garcia DM, Teixeira D, Longo-Maugéri IM, Katz S, Barbiéri CL. Front Microbiol; 2017 Mar; 8():333. PubMed ID: 28321209 [Abstract] [Full Text] [Related]
16. Leishmanicidal Activity of Isoselenocyanate Derivatives. Fernández-Rubio C, Larrea E, Peña Guerrero J, Sesma Herrero E, Gamboa I, Berrio C, Plano D, Amin S, Sharma AK, Nguewa PA. Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478164 [Abstract] [Full Text] [Related]
17. A novel organotellurium compound (RT-01) as a new antileishmanial agent. Lima CB, Arrais-Silva WW, Cunha RL, Giorgio S. Korean J Parasitol; 2009 Sep; 47(3):213-8. PubMed ID: 19724693 [Abstract] [Full Text] [Related]